{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:19:50Z","timestamp":1794277190131,"version":"4.9.0"},"reference-count":273,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00018-017-2714-7","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T12:19:18Z","timestamp":1511266758000},"page":"871-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Signaling pathways and mesenchymal transition in pediatric high-grade glioma"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-9633","authenticated-orcid":false,"given":"Micha\u00ebl H.","family":"Meel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Schaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan J. L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-947X","authenticated-orcid":false,"given":"Esther","family":"Hulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"2714_CR1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/pbc.24427","volume":"60","author":"A Gajjar","year":"2013","unstructured":"Gajjar A, Packer RJ, Foreman NK, Cohen K, Haas-Kogan D, Merchant TE (2013) Children\u2019s Oncology Group\u2019s 2013 blueprint for research: central nervous system tumors. Pediatr Blood Cancer 60:1022\u20131026","journal-title":"Pediatr Blood Cancer"},{"key":"2714_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-017-2514-9","volume":"134","author":"SEMV van Zanten","year":"2017","unstructured":"van Zanten SEMV et al (2017) External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry. J Neurooncol 134:231\u2013240","journal-title":"J Neurooncol"},{"key":"2714_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrc3811","volume":"14","author":"C Jones","year":"2014","unstructured":"Jones C, Baker SJ (2014) Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer 14:651\u2013661","journal-title":"Nat Rev Cancer"},{"key":"2714_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA et al (2012) K27\u00a0M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439\u2013447","journal-title":"Acta Neuropathol"},{"key":"2714_CR5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231","journal-title":"Nature"},{"key":"2714_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437","journal-title":"Cancer Cell"},{"key":"2714_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253","journal-title":"Nat Genet"},{"key":"2714_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/2017.2.PEDS1665","volume":"20","author":"C Hamisch","year":"2017","unstructured":"Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI (2017) Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 20:261\u2013268","journal-title":"J Neurosurg Pediatr"},{"key":"2714_CR9","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/neuonc\/now038","volume":"18","author":"RI Jakacki","year":"2016","unstructured":"Jakacki RI et al (2016) Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children\u2019s Oncology Group ACNS0423 study. Neuro Oncol 18:1442\u20131450","journal-title":"Neuro Oncol"},{"key":"2714_CR10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.2005.04.6599","volume":"24","author":"SS Donaldson","year":"2006","unstructured":"Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266\u20131272","journal-title":"J Clin Oncol"},{"key":"2714_CR11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2714_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"MS Carro","year":"2010","unstructured":"Carro MS et al (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318\u2013325","journal-title":"Nature"},{"key":"2714_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/onc.2015.132","volume":"35","author":"C Raggi","year":"2016","unstructured":"Raggi C, Mousa HS, Correnti M, Sica A, Invernizzi P (2016) Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies. Oncogene 35:671\u2013682","journal-title":"Oncogene"},{"key":"2714_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","volume":"9","author":"HS Phillips","year":"2006","unstructured":"Phillips HS et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157\u2013173","journal-title":"Cancer Cell"},{"key":"2714_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1476-4598-9-234","volume":"9","author":"F Ducray","year":"2010","unstructured":"Ducray F et al (2010) An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients. Mol Cancer 9:234","journal-title":"Mol Cancer"},{"key":"2714_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, de Garcia HA (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84\u201389","journal-title":"Nat Cell Biol"},{"key":"2714_CR17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/onc.2012.169","volume":"32","author":"C Dong","year":"2013","unstructured":"Dong C et al (2013) Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene 32:1351\u20131362","journal-title":"Oncogene"},{"key":"2714_CR18","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2015.04.021","volume":"51","author":"NM Ghahhari","year":"2015","unstructured":"Ghahhari NM, Babashah S (2015) Interplay between microRNAs and WNT\/beta-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer 51:1638\u20131649","journal-title":"Eur J Cancer"},{"key":"2714_CR19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-014-0062-0","volume":"33","author":"S Kaufhold","year":"2014","unstructured":"Kaufhold S, Bonavida B (2014) Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res 33:62","journal-title":"J Exp Clin Cancer Res"},{"key":"2714_CR20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2013.12.004","volume":"723","author":"H Wang","year":"2014","unstructured":"Wang H et al (2014) Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT\/beta-catenin\/Snail signaling pathway. Eur J Pharmacol 723:156\u2013166","journal-title":"Eur J Pharmacol"},{"key":"2714_CR21","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2741\/3433","volume":"14","author":"CC Alves","year":"2009","unstructured":"Alves CC, Carneiro F, Hoefler H, Becker KF (2009) Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci 14:3035\u20133050 (Landmark. Ed)","journal-title":"Front Biosci"},{"key":"2714_CR22","doi-asserted-by":"crossref","first-page":"e40378","DOI":"10.1371\/journal.pone.0040378","volume":"7","author":"N Fenouille","year":"2012","unstructured":"Fenouille N et al (2012) The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. PLoS One 7:e40378","journal-title":"PLoS One"},{"key":"2714_CR23","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1038\/onc.2011.562","volume":"31","author":"P Villagrasa","year":"2012","unstructured":"Villagrasa P et al (2012) Akt2 interacts with Snail1 in the E-cadherin promoter. Oncogene 31:4022\u20134033","journal-title":"Oncogene"},{"key":"2714_CR24","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2174\/13816128113199990512","volume":"20","author":"Y Lin","year":"2014","unstructured":"Lin Y, Dong C, Zhou BP (2014) Epigenetic regulation of EMT: the Snail story. Curr Pharm Des 20:1698\u20131705","journal-title":"Curr Pharm Des"},{"key":"2714_CR25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yexcr.2012.07.019","volume":"319","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shang Y (2013) Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp Cell Res 319:160\u2013169","journal-title":"Exp Cell Res"},{"key":"2714_CR26","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68:3033\u20133046","journal-title":"Cell Mol Life Sci"},{"key":"2714_CR27","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-3173","volume":"21","author":"HY Jung","year":"2015","unstructured":"Jung HY, Fattet L, Yang J (2015) Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clin Cancer Res 21:962\u2013968","journal-title":"Clin Cancer Res"},{"key":"2714_CR28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00441-014-1953-2","volume":"358","author":"ZC Liu","year":"2014","unstructured":"Liu ZC et al (2014) Snail regulated by PKC\/GSK-3beta pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells. Cell Tissue Res 358:491\u2013502","journal-title":"Cell Tissue Res"},{"key":"2714_CR29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbamcr.2011.01.003","volume":"1813","author":"M Sun","year":"2011","unstructured":"Sun M, Song L, Zhou T, Gillespie GY, Jope RS (2011) The role of DDX3 in regulating Snail. Biochim Biophys Acta 1813:438\u2013447","journal-title":"Biochim Biophys Acta"},{"key":"2714_CR30","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1038\/emboj.2013.236","volume":"32","author":"S Hahn","year":"2013","unstructured":"Hahn S, Jackstadt R, Siemens H, Hunten S, Hermeking H (2013) SNAIL and miR-34a feed-forward regulation of ZNF281\/ZBP99 promotes epithelial-mesenchymal transition. EMBO J 32:3079\u20133095","journal-title":"EMBO J"},{"key":"2714_CR31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","volume":"13","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shi J, Chai K, Ying X, Zhou BP (2013) The role of Snail in EMT and tumorigenesis. Curr Cancer Drug Targets 13:963\u2013972","journal-title":"Curr Cancer Drug Targets"},{"key":"2714_CR32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/0008-5472.CAN-10-2330","volume":"71","author":"E Casas","year":"2011","unstructured":"Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J (2011) Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 71:245\u2013254","journal-title":"Cancer Res"},{"key":"2714_CR33","doi-asserted-by":"crossref","first-page":"39209","DOI":"10.1074\/jbc.M206400200","volume":"277","author":"S Guaita","year":"2002","unstructured":"Guaita S et al (2002) Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 277:39209\u201339216","journal-title":"J Biol Chem"},{"key":"2714_CR34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/neuonc\/not239","volume":"16","author":"R Mahabir","year":"2014","unstructured":"Mahabir R et al (2014) Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro Oncol 16:671\u2013685","journal-title":"Neuro Oncol"},{"key":"2714_CR35","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1038\/onc.2013.67","volume":"32","author":"K Savary","year":"2013","unstructured":"Savary K et al (2013) Snail depletes the tumorigenic potential of glioblastoma. Oncogene 32:5409\u20135420","journal-title":"Oncogene"},{"key":"2714_CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10571-010-9643-4","volume":"31","author":"SP Han","year":"2011","unstructured":"Han SP et al (2011) SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol Neurobiol 31:489\u2013496","journal-title":"Cell Mol Neurobiol"},{"key":"2714_CR37","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.3892\/ol.2017.5875","volume":"13","author":"CD Kuhnol","year":"2017","unstructured":"Kuhnol CD, Wurfel C, Staege MS, Kramm C (2017) Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells. Oncol Lett 13:3882\u20133888","journal-title":"Oncol Lett"},{"key":"2714_CR38","doi-asserted-by":"crossref","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","volume":"7","author":"S Puget","year":"2012","unstructured":"Puget S et al (2012) Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7:e30313","journal-title":"PLoS One"},{"key":"2714_CR39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1440-1789.2009.01072.x","volume":"30","author":"J Myung","year":"2010","unstructured":"Myung J, Cho BK, Kim YS, Park SH (2010) Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas. Neuropathology 30:224\u2013231","journal-title":"Neuropathology"},{"key":"2714_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1471-2407-10-301","volume":"10","author":"HW Yang","year":"2010","unstructured":"Yang HW, Menon LG, Black PM, Carroll RS, Johnson MD (2010) SNAI2\/Slug promotes growth and invasion in human gliomas. BMC Cancer 10:301","journal-title":"BMC Cancer"},{"key":"2714_CR41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ijc.27708","volume":"132","author":"L Hill","year":"2013","unstructured":"Hill L, Browne G, Tulchinsky E (2013) ZEB\/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer 132:745\u2013754","journal-title":"Int J Cancer"},{"key":"2714_CR42","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","volume":"138","author":"Y Shimono","year":"2009","unstructured":"Shimono Y et al (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138:592\u2013603","journal-title":"Cell"},{"key":"2714_CR43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner U et al (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11:1487\u20131495","journal-title":"Nat Cell Biol"},{"key":"2714_CR44","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-12-4082","volume":"73","author":"B Cieply","year":"2013","unstructured":"Cieply B, Farris J, Denvir J, Ford HL, Frisch SM (2013) Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. Cancer Res 73:6299\u20136309","journal-title":"Cancer Res"},{"key":"2714_CR45","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl FA et al (2013) The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 5:1196\u20131212","journal-title":"EMBO Mol Med"},{"key":"2714_CR46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bpa.12240","volume":"25","author":"UD Kahlert","year":"2015","unstructured":"Kahlert UD et al (2015) ZEB1 promotes invasion in human fetal neural stem cells and hypoxic glioma neurospheres. Brain Pathol 25:724\u2013732","journal-title":"Brain Pathol"},{"key":"2714_CR47","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1038\/onc.2016.100","volume":"35","author":"L Zhang","year":"2016","unstructured":"Zhang L et al (2016) SHP-2-upregulated ZEB1 is important for PDGFRalpha-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Oncogene 35:5641\u20135652","journal-title":"Oncogene"},{"key":"2714_CR48","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh BS et al (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999\u20134006","journal-title":"J Clin Oncol"},{"key":"2714_CR49","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","volume":"28","author":"BS Paugh","year":"2010","unstructured":"Paugh BS et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061\u20133068","journal-title":"J Clin Oncol"},{"key":"2714_CR50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444\u2013450","journal-title":"Nat Genet"},{"key":"2714_CR51","doi-asserted-by":"crossref","first-page":"e38842","DOI":"10.1371\/journal.pone.0038842","volume":"7","author":"S Qi","year":"2012","unstructured":"Qi S et al (2012) ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS One 7:e38842","journal-title":"PLoS One"},{"key":"2714_CR52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.25332","volume":"128","author":"S Yeasmin","year":"2011","unstructured":"Yeasmin S et al (2011) Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition. Int J Cancer 128:94\u2013104","journal-title":"Int J Cancer"},{"key":"2714_CR53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","volume":"449","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682\u2013688","journal-title":"Nature"},{"key":"2714_CR54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1541-7786.MCR-10-0529","volume":"9","author":"X Li","year":"2011","unstructured":"Li X et al (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9:824\u2013833","journal-title":"Mol Cancer Res"},{"key":"2714_CR55","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/onc.2009.180","volume":"28","author":"NJ Sullivan","year":"2009","unstructured":"Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28:2940\u20132947","journal-title":"Oncogene"},{"key":"2714_CR56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/jclinpath-2015-202868","volume":"68","author":"K Nordfors","year":"2015","unstructured":"Nordfors K et al (2015) Twist predicts poor outcome of patients with astrocytic glioma. J Clin Pathol 68:905\u2013912","journal-title":"J Clin Pathol"},{"key":"2714_CR57","doi-asserted-by":"crossref","first-page":"21029","DOI":"10.18632\/oncotarget.3763","volume":"6","author":"S Krossa","year":"2015","unstructured":"Krossa S, Schmitt AD, Hattermann K, Fritsch J, Scheidig AJ, Mehdorn HM, Held-Feindt J (2015) Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1. Oncotarget 6:21029\u201321045","journal-title":"Oncotarget"},{"key":"2714_CR58","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.18632\/oncotarget.367","volume":"2","author":"KK Velpula","year":"2011","unstructured":"Velpula KK, Dasari VR, Tsung AJ, Dinh DH, Rao JS (2011) Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget 2:1028\u20131042","journal-title":"Oncotarget"},{"key":"2714_CR59","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/bcr3219","volume":"14","author":"R Iwanaga","year":"2012","unstructured":"Iwanaga R et al (2012) Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res 14:R100","journal-title":"Breast Cancer Res"},{"key":"2714_CR60","first-page":"631","volume":"7","author":"Z Li","year":"2014","unstructured":"Li Z et al (2014) Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion. Int J Clin Exp Pathol 7:631\u2013639","journal-title":"Int J Clin Exp Pathol"},{"key":"2714_CR61","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1172\/JCI37815","volume":"119","author":"DS Micalizzi","year":"2009","unstructured":"Micalizzi DS et al (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-\u00ce2 signaling. J Clin Invest 119:2678\u20132690","journal-title":"J Clin Invest"},{"key":"2714_CR62","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/carcin\/bgu050","volume":"35","author":"H Xu","year":"2014","unstructured":"Xu H, Zhang Y, Altomare D, Pe\u00f1a MM, Wan F, Pirisi L, Creek KE (2014) Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes. Carcinogenesis 35:1379\u20131388","journal-title":"Carcinogenesis"},{"key":"2714_CR63","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1038\/onc.2011.646","volume":"31","author":"H Ono","year":"2012","unstructured":"Ono H et al (2012) SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 31:4923\u20134934","journal-title":"Oncogene"},{"key":"2714_CR64","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI37691","volume":"119","author":"EL McCoy","year":"2009","unstructured":"McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, Heichman KA, Welm AL, Ford HL (2009) Six1 expands the mouse mammary epithelial stem\/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest 119:2663\u20132677","journal-title":"J Clin Invest"},{"key":"2714_CR65","first-page":"1823","volume":"5","author":"T Tian","year":"2015","unstructured":"Tian T, Li A, Lu H, Luo R, Zhang M, Li Z (2015) Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor. Am J Cancer Res 5:1823\u20131830","journal-title":"Am J Cancer Res"},{"key":"2714_CR66","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.celrep.2013.04.035","volume":"3","author":"RM Auvergne","year":"2013","unstructured":"Auvergne RM et al (2013) Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes. Cell Rep 3:2127\u20132141","journal-title":"Cell Rep"},{"key":"2714_CR67","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","volume":"19","author":"J Massague","year":"2005","unstructured":"Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783\u20132810","journal-title":"Genes Dev"},{"key":"2714_CR68","doi-asserted-by":"crossref","first-page":"36803","DOI":"10.1074\/jbc.M005912200","volume":"275","author":"AV Bakin","year":"2000","unstructured":"Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803\u201336810","journal-title":"J Biol Chem"},{"key":"2714_CR69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577\u2013584","journal-title":"Nature"},{"key":"2714_CR70","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451\u2013456","journal-title":"Nat Genet"},{"key":"2714_CR71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor KR et al (2014) Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46:457\u2013461","journal-title":"Nat Genet"},{"key":"2714_CR72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2369-11-31","volume":"11","author":"CP Bramlage","year":"2010","unstructured":"Bramlage CP et al (2010) Bone morphogenetic protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis. BMC Nephrol 11:31","journal-title":"BMC Nephrol"},{"key":"2714_CR73","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso AM et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 46:462\u2013466","journal-title":"Nat Genet"},{"key":"2714_CR74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20120252","volume":"124","author":"XM Meng","year":"2013","unstructured":"Meng XM, Chung AC, Lan HY (2013) Role of the TGF-beta\/BMP-7\/Smad pathways in renal diseases. Clin Sci (Lond) 124:243\u2013254","journal-title":"Clin Sci (Lond)"},{"key":"2714_CR75","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0960-9822(06)00413-1","volume":"7","author":"PN Adler","year":"1997","unstructured":"Adler PN, Krasnow RE, Liu J (1997) Tissue polarity points from cells that have higher Frizzled levels towards cells that have lower Frizzled levels. Curr Biol 7:940\u2013949","journal-title":"Curr Biol"},{"key":"2714_CR76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/382225a0","volume":"382","author":"P Bhanot","year":"1996","unstructured":"Bhanot P et al (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225\u2013230","journal-title":"Nature"},{"key":"2714_CR77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1119(98)00311-4","volume":"216","author":"PJ Hey","year":"1998","unstructured":"Hey PJ et al (1998) Cloning of a novel member of the low-density lipoprotein receptor family. Gene 216:103\u2013111","journal-title":"Gene"},{"key":"2714_CR78","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1006\/bbrc.1998.9061","volume":"248","author":"SD Brown","year":"1998","unstructured":"Brown SD et al (1998) Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. Biochem Biophys Res Commun 248:879\u2013888","journal-title":"Biochem Biophys Res Commun"},{"key":"2714_CR79","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","volume":"16","author":"H Aberle","year":"1997","unstructured":"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797\u20133804","journal-title":"EMBO J"},{"key":"2714_CR80","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/emboj\/17.5.1371","volume":"17","author":"S Ikeda","year":"1998","unstructured":"Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17:1371\u20131384","journal-title":"EMBO J"},{"key":"2714_CR81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0960-9822(98)70082-X","volume":"8","author":"F Fagotto","year":"1998","unstructured":"Fagotto F, Gluck U, Gumbiner BM (1998) Nuclear localization signal-independent and importin\/karyopherin-independent nuclear import of beta-catenin. Curr Biol 8:181\u2013190","journal-title":"Curr Biol"},{"key":"2714_CR82","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1091\/mbc.10.4.1119","volume":"10","author":"F Yokoya","year":"1999","unstructured":"Yokoya F, Imamoto N, Tachibana T, Yoneda Y (1999) beta-catenin can be transported into the nucleus in a Ran-unassisted manner. Mol Biol Cell 10:1119\u20131131","journal-title":"Mol Biol Cell"},{"key":"2714_CR83","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00018-005-4552-2","volume":"62","author":"F Ille","year":"2005","unstructured":"Ille F, Sommer L (2005) Wnt signaling: multiple functions in neural development. Cell Mol Life Sci 62:1100\u20131108","journal-title":"Cell Mol Life Sci"},{"key":"2714_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-9525(98)01634-5","volume":"15","author":"R Nusse","year":"1999","unstructured":"Nusse R (1999) WNT targets. Repression and activation. Trends Genet 15:1\u20133","journal-title":"Trends Genet"},{"key":"2714_CR85","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1242\/jcs.003129","volume":"120","author":"A Nawshad","year":"2007","unstructured":"Nawshad A, Medici D, Liu CC, Hay ED (2007) TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 120:1646\u20131653","journal-title":"J Cell Sci"},{"key":"2714_CR86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.canlet.2014.10.008","volume":"356","author":"W Xu","year":"2015","unstructured":"Xu W, Wang Z, Zhang W, Qian K, Li H, Kong D, Li Y, Tang Y (2015) Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt\/beta-catenin signaling pathway. Cancer Lett 356:613\u2013627","journal-title":"Cancer Lett"},{"key":"2714_CR87","doi-asserted-by":"crossref","first-page":"16654","DOI":"10.1073\/pnas.1205822109","volume":"109","author":"ZQ Wu","year":"2012","unstructured":"Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG, Weiss SJ (2012) Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 109:16654\u201316659","journal-title":"Proc Natl Acad Sci USA"},{"key":"2714_CR88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/07357907.2010.512595","volume":"29","author":"JH Zhao","year":"2011","unstructured":"Zhao JH, Luo Y, Jiang YG, He DL, Wu CT (2011) Knockdown of beta-Catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1alpha. Cancer Invest 29:377\u2013382","journal-title":"Cancer Invest"},{"key":"2714_CR89","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/or.2014.3012","volume":"31","author":"L Chen","year":"2014","unstructured":"Chen L et al (2014) A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo. Oncol Rep 31:1573\u20131580","journal-title":"Oncol Rep"},{"key":"2714_CR90","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/carcin\/bgt027","volume":"34","author":"Q Zhang","year":"2013","unstructured":"Zhang Q et al (2013) Wnt\/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis 34:962\u2013973","journal-title":"Carcinogenesis"},{"key":"2714_CR91","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4161\/cbt.11.8.14894","volume":"11","author":"M Rossi","year":"2011","unstructured":"Rossi M et al (2011) beta-catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biol Ther 11:753\u2013761","journal-title":"Cancer Biol Ther"},{"key":"2714_CR92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10238-010-0110-9","volume":"11","author":"C Liu","year":"2011","unstructured":"Liu C et al (2011) Wnt\/beta-Catenin pathway in human glioma: expression pattern and clinical\/prognostic correlations. Clin Exp Med 11:105\u2013112","journal-title":"Clin Exp Med"},{"key":"2714_CR93","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12253-009-9219-0","volume":"16","author":"LY Zhang","year":"2010","unstructured":"Zhang LY et al (2010) Reduced beta-catenin expression is associated with good prognosis in Astrocytoma. Pathol Oncol Res 16:253\u2013257","journal-title":"Pathol Oncol Res"},{"key":"2714_CR94","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1349-7006.2010.01815.x","volume":"102","author":"M Kamino","year":"2011","unstructured":"Kamino M et al (2011) Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci 102:540\u2013548","journal-title":"Cancer Sci"},{"key":"2714_CR95","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s12032-010-9476-5","volume":"28","author":"X Liu","year":"2011","unstructured":"Liu X, Wang L, Zhao S, Ji X, Luo Y, Ling F (2011) beta-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells. Med Oncol 28:608\u2013614","journal-title":"Med Oncol"},{"key":"2714_CR96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2009.03.016","volume":"55","author":"GR Sareddy","year":"2009","unstructured":"Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP (2009) Activation of Wnt\/beta-catenin\/Tcf signaling pathway in human astrocytomas. Neurochem Int 55:307\u2013317","journal-title":"Neurochem Int"},{"key":"2714_CR97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2012.05.024","volume":"325","author":"UD Kahlert","year":"2012","unstructured":"Kahlert UD et al (2012) Activation of canonical WNT\/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett 325:42\u201353","journal-title":"Cancer Lett"},{"key":"2714_CR98","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2014.11.113","volume":"456","author":"E Nie","year":"2015","unstructured":"Nie E, Zhang X, Xie S, Shi Q, Hu J, Meng Q, Zhou X, Yu R (2015) Beta-catenin is involved in Bex2 down-regulation induced glioma cell invasion\/migration inhibition. Biochem Biophys Res Commun 456:494\u2013499","journal-title":"Biochem Biophys Res Commun"},{"key":"2714_CR99","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/neuonc\/nor034","volume":"13","author":"J Zhang","year":"2011","unstructured":"Zhang J et al (2011) High beta-catenin\/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol 13:600\u2013609","journal-title":"Neuro Oncol"},{"key":"2714_CR100","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1038\/cddis.2013.32","volume":"4","author":"E Rampazzo","year":"2013","unstructured":"Rampazzo E et al (2013) Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis 4:e500","journal-title":"Cell Death Dis"},{"key":"2714_CR101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mcn.2013.01.001","volume":"54","author":"N Kaur","year":"2013","unstructured":"Kaur N, Chettiar S, Rathod S, Rath P, Muzumdar D, Shaikh ML, Shiras A (2013) Wnt3a mediated activation of Wnt\/beta-catenin signaling promotes tumor progression in glioblastoma. Mol Cell Neurosci 54:44\u201357","journal-title":"Mol Cell Neurosci"},{"key":"2714_CR102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jgm.2693","volume":"15","author":"K Wang","year":"2013","unstructured":"Wang K, Park JO, Zhang M (2013) Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and beta-catenin. J Gene Med 15:42\u201350","journal-title":"J Gene Med"},{"key":"2714_CR103","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/labinvest.2011.161","volume":"92","author":"Y Kim","year":"2012","unstructured":"Kim Y et al (2012) Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 92:466\u2013473","journal-title":"Lab Invest"},{"key":"2714_CR104","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s40478-014-0174-y","volume":"2","author":"N Zhukova","year":"2014","unstructured":"Zhukova N et al (2014) WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathol Commun 2:174","journal-title":"Acta Neuropathol Commun"},{"key":"2714_CR105","doi-asserted-by":"crossref","first-page":"e0127517","DOI":"10.1371\/journal.pone.0127517","volume":"10","author":"G Bhuvanalakshmi","year":"2015","unstructured":"Bhuvanalakshmi G, Arfuso F, Millward M, Dharmarajan A, Warrier S (2015) Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties. PLoS One 10:e0127517","journal-title":"PLoS One"},{"key":"2714_CR106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3727\/096504013X13786659070154","volume":"21","author":"S Warrier","year":"2013","unstructured":"Warrier S, Balu SK, Kumar AP, Millward M, Dharmarajan A (2013) Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells. Oncol Res 21:93\u2013102","journal-title":"Oncol Res"},{"key":"2714_CR107","doi-asserted-by":"crossref","first-page":"27300","DOI":"10.18632\/oncotarget.15934","volume":"8","author":"M Wiese","year":"2017","unstructured":"Wiese M et al (2017) The beta-catenin\/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Oncotarget 8:27300\u201327313","journal-title":"Oncotarget"},{"key":"2714_CR108","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","volume":"4","author":"Y Komiya","year":"2008","unstructured":"Komiya Y, Habas R (2008) Wnt signal transduction pathways. Organogenesis 4:68\u201375","journal-title":"Organogenesis"},{"key":"2714_CR109","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1101\/gad.1957710","volume":"24","author":"L Grumolato","year":"2010","unstructured":"Grumolato L et al (2010) Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24:2517\u20132530","journal-title":"Genes Dev"},{"key":"2714_CR110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/1471-2407-13-496","volume":"13","author":"H Bo","year":"2013","unstructured":"Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, Zhu M (2013) Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer 13:496","journal-title":"BMC Cancer"},{"key":"2714_CR111","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2443.2011.01487.x","volume":"16","author":"D Ren","year":"2011","unstructured":"Ren D, Minami Y, Nishita M (2011) Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 16:304\u2013315","journal-title":"Genes Cells"},{"key":"2714_CR112","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3892\/ijo.2017.3937","volume":"50","author":"T Asano","year":"2017","unstructured":"Asano T et al (2017) Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. Int J Oncol 50:1647\u20131654","journal-title":"Int J Oncol"},{"key":"2714_CR113","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ygyno.2014.06.004","volume":"134","author":"CE Ford","year":"2014","unstructured":"Ford CE et al (2014) The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecol Oncol 134:338\u2013345","journal-title":"Gynecol Oncol"},{"key":"2714_CR114","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.18632\/oncotarget.3133","volume":"6","author":"Y Zhang","year":"2015","unstructured":"Zhang Y et al (2015) EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells. Oncotarget 6:7244\u20137261","journal-title":"Oncotarget"},{"key":"2714_CR115","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-16-1693","volume":"77","author":"E Binda","year":"2017","unstructured":"Binda E et al (2017) Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells. Cancer Res 77:996\u20131007","journal-title":"Cancer Res"},{"key":"2714_CR116","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10014-013-0153-1","volume":"31","author":"H Hirano","year":"2014","unstructured":"Hirano H et al (2014) Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining. Brain Tumor Pathol 31:85\u201393","journal-title":"Brain Tumor Pathol"},{"issue":"1281\u20131295","key":"2714_CR117","first-page":"e18","volume":"167","author":"B Hu","year":"2016","unstructured":"Hu B et al (2016) Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell 167(1281\u20131295):e18","journal-title":"Cell"},{"key":"2714_CR118","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.prp.2015.10.001","volume":"211","author":"Y Kim","year":"2015","unstructured":"Kim Y, Hong M, Do IG, Ha SY, Lee D, Suh YL (2015) Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. Pathol Res Pract 211:963\u2013972","journal-title":"Pathol Res Pract"},{"key":"2714_CR119","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1158\/0008-5472.CAN-11-1531","volume":"71","author":"T Pulvirenti","year":"2011","unstructured":"Pulvirenti T, Van Der Heijden M, Droms LA, Huse JT, Tabar V, Hall A (2011) Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. Cancer Res 71:7280\u20137290","journal-title":"Cancer Res"},{"key":"2714_CR120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/onc.2015.61","volume":"35","author":"I Vassallo","year":"2016","unstructured":"Vassallo I, Zinn P, Lai M, Rajakannu P, Hamou MF, Hegi ME (2016) WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 35:12\u201321","journal-title":"Oncogene"},{"key":"2714_CR121","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1038\/onc.2017.126","volume":"36","author":"JH Wald","year":"2017","unstructured":"Wald JH et al (2017) Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene 36:5158\u20135167","journal-title":"Oncogene"},{"key":"2714_CR122","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2007.07.011","volume":"257","author":"JM Yu","year":"2007","unstructured":"Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW, Jung JS (2007) Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257:172\u2013181","journal-title":"Cancer Lett"},{"key":"2714_CR123","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931\u2013940","journal-title":"Nat Cell Biol"},{"key":"2714_CR124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1083\/jcb.200409067","volume":"168","author":"RE Bachelder","year":"2005","unstructured":"Bachelder RE, Yoon SO, Franci C, De Herreros AG, Mercurio AM (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168:29\u201333","journal-title":"J Cell Biol"},{"key":"2714_CR125","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.cellsig.2012.08.004","volume":"24","author":"K Wu","year":"2012","unstructured":"Wu K et al (2012) PI3\u00a0K\/Akt to GSK3beta\/beta-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Cell Signal 24:2273\u20132282","journal-title":"Cell Signal"},{"key":"2714_CR126","doi-asserted-by":"crossref","first-page":"20177","DOI":"10.18632\/oncotarget.3896","volume":"6","author":"C Peng","year":"2015","unstructured":"Peng C et al (2015) The 14-3-3sigma\/GSK3beta\/beta-catenin\/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer. Oncotarget 6:20177\u201320189","journal-title":"Oncotarget"},{"key":"2714_CR127","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0270","volume":"2","author":"G Xue","year":"2012","unstructured":"Xue G, Restuccia DF, Lan Q, Hynx D, Dirnhofer S, Hess D, Ruegg C, Hemmings BA (2012) Akt\/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3\u00a0K\/Akt and TGF-beta signaling axes. Cancer Discov 2:248\u2013259","journal-title":"Cancer Discov"},{"key":"2714_CR128","doi-asserted-by":"crossref","first-page":"e56664","DOI":"10.1371\/journal.pone.0056664","volume":"8","author":"H Wang","year":"2013","unstructured":"Wang H et al (2013) Epithelial-mesenchymal transition (EMT) induced by TNF-alpha requires AKT\/GSK-3beta-mediated stabilization of snail in colorectal cancer. PLoS One 8:e56664","journal-title":"PLoS One"},{"key":"2714_CR129","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/bjc.2012.24","volume":"106","author":"S Maseki","year":"2012","unstructured":"Maseki S et al (2012) Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt\/GSK-3beta\/snail signalling pathway. Br J Cancer 106:1196\u20131204","journal-title":"Br J Cancer"},{"key":"2714_CR130","first-page":"461","volume":"40","author":"M Jiao","year":"2012","unstructured":"Jiao M, Nan KJ (2012) Activation of PI3 kinase\/Akt\/HIF-1alpha pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. Int J Oncol 40:461\u2013468","journal-title":"Int J Oncol"},{"key":"2714_CR131","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1038\/cddis.2013.407","volume":"4","author":"L Chang","year":"2013","unstructured":"Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y (2013) Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3\u00a0K\/Akt\/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 4:e875","journal-title":"Cell Death Dis"},{"key":"2714_CR132","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/0008-5472.CAN-09-0578","volume":"70","author":"N Baryawno","year":"2010","unstructured":"Baryawno N, Sveinbjornsson B, Eksborg S, Chen CS, Kogner P, Johnsen JI (2010) Small-molecule inhibitors of phosphatidylinositol 3-kinase\/Akt signaling inhibit Wnt\/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res 70:266\u2013276","journal-title":"Cancer Res"},{"key":"2714_CR133","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.999.65.3","volume":"65","author":"R Blum","year":"2005","unstructured":"Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G, Kloog Y (2005) Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res 65:999\u20131006","journal-title":"Cancer Res"},{"key":"2714_CR134","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2010.09.097","volume":"1366","author":"L Han","year":"2010","unstructured":"Han L et al (2010) Inactivation of PI3\u00a0K\/AKT signaling inhibits glioma cell growth through modulation of beta-catenin-mediated transcription. Brain Res 1366:9\u201317","journal-title":"Brain Res"},{"key":"2714_CR135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1541-7786.MCR-05-0234","volume":"4","author":"N Pore","year":"2006","unstructured":"Pore N, Jiang Z, Shu HK, Bernhard E, Kao GD, Maity A (2006) Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res 4:471\u2013479","journal-title":"Mol. Cancer Res"},{"key":"2714_CR136","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/onc.2010.620","volume":"30","author":"HJ Kwak","year":"2011","unstructured":"Kwak HJ et al (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30:2433\u20132442","journal-title":"Oncogene"},{"key":"2714_CR137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-14-17","volume":"14","author":"EJ Choi","year":"2014","unstructured":"Choi EJ, Cho BJ, Lee DJ, Hwang YH, Chun SH, Kim HH, Kim IA (2014) Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3\u00a0K-AKT-mTOR signaling, HSP90 and histone deacetylases. BMC Cancer 14:17","journal-title":"BMC Cancer"},{"key":"2714_CR138","unstructured":"Robison NJ, Kieran MW (2012) Identification of novel biologic targets in the treatment of newly diagnosed diffuse intrinsic pontine glioma. In: 2012 ASCO annual meeting, vol 2, pp 625\u2013628"},{"key":"2714_CR139","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pbc.24060","volume":"58","author":"J Grill","year":"2012","unstructured":"Grill J, Puget S, Andreiuolo F, Philippe C, MacConaill L, Kieran MW (2012) Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 58:489\u2013491","journal-title":"Pediatr Blood Cancer"},{"key":"2714_CR140","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","volume":"7","author":"H Nikbakht","year":"2016","unstructured":"Nikbakht H et al (2016) Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat Commun 7:11185","journal-title":"Nat Commun"},{"key":"2714_CR141","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","volume":"89","author":"EK Kim","year":"2015","unstructured":"Kim EK, Choi EJ (2015) Compromised MAPK signaling in human diseases: an update. Arch Toxicol 89:867\u2013882","journal-title":"Arch Toxicol"},{"key":"2714_CR142","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1476-4598-10-118","volume":"10","author":"E Makrodouli","year":"2011","unstructured":"Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S, Pintzas A (2011) BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol Cancer 10:118","journal-title":"Mol Cancer"},{"key":"2714_CR143","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-10-2914","volume":"71","author":"J Hong","year":"2011","unstructured":"Hong J, Zhou J, Fu J, He T, Qin J, Wang L, Liao L, Xu J (2011) Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res 71:3980\u20133990","journal-title":"Cancer Res"},{"key":"2714_CR144","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1242\/jcs.00091","volume":"115","author":"M Grande","year":"2002","unstructured":"Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE, Nilsson M (2002) Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 115:4227\u20134236","journal-title":"J Cell Sci"},{"key":"2714_CR145","doi-asserted-by":"crossref","first-page":"e96365","DOI":"10.1371\/journal.pone.0096365","volume":"9","author":"X Chen","year":"2014","unstructured":"Chen X, Xiao W, Wang W, Luo L, Ye S, Liu Y (2014) The complex interplay between ERK1\/2, TGFbeta\/Smad, and Jagged\/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells. PLoS One 9:e96365","journal-title":"PLoS One"},{"key":"2714_CR146","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/0008-5472.CAN-11-3132","volume":"72","author":"DJ Mulholland","year":"2012","unstructured":"Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M, Wu H (2012) Pten loss and RAS\/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem\/progenitor cells. Cancer Res 72:1878\u20131889","journal-title":"Cancer Res"},{"key":"2714_CR147","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1947601910373795","volume":"1","author":"K Lin","year":"2010","unstructured":"Lin K, Baritaki S, Militello L, Malaponte G, Bevelacqua Y, Bonavida B (2010) The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB\/Snail\/RKIP\/PTEN circuit. Genes Cancer 1:409\u2013420","journal-title":"Genes Cancer"},{"key":"2714_CR148","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1002\/ijc.29154","volume":"136","author":"M Koh","year":"2015","unstructured":"Koh M et al (2015) Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition. Int J Cancer 136:E508\u2013E520","journal-title":"Int J Cancer"},{"key":"2714_CR149","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2014.06.004","volume":"158","author":"DD Shao","year":"2014","unstructured":"Shao DD et al (2014) KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158:171\u2013184","journal-title":"Cell"},{"key":"2714_CR150","doi-asserted-by":"crossref","first-page":"e70427","DOI":"10.1371\/journal.pone.0070427","volume":"8","author":"DC Voon","year":"2013","unstructured":"Voon DC et al (2013) EMT-induced stemness and tumorigenicity are fueled by the EGFR\/Ras pathway. PLoS One 8:e70427","journal-title":"PLoS One"},{"key":"2714_CR151","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-11-0399","volume":"10","author":"GP Botta","year":"2012","unstructured":"Botta GP, Reginato MJ, Reichert M, Rustgi AK, Lelkes PI (2012) Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. Mol Cancer Res 10:183\u2013196","journal-title":"Mol Cancer Res"},{"key":"2714_CR152","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.freeradbiomed.2011.11.024","volume":"52","author":"D Nagarajan","year":"2012","unstructured":"Nagarajan D, Melo T, Deng Z, Almeida C, Zhao W (2012) ERK\/GSK3beta\/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. Free Radic Biol Med 52:983\u2013992","journal-title":"Free Radic Biol Med"},{"key":"2714_CR153","doi-asserted-by":"crossref","first-page":"11850","DOI":"10.1074\/jbc.M111.258236","volume":"287","author":"W Zhang","year":"2012","unstructured":"Zhang W et al (2012) Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET\/extracellular signal-regulated kinase (ERK) signaling. J Biol Chem 287:11850\u201311858","journal-title":"J Biol Chem"},{"key":"2714_CR154","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/bjc.2013.550","volume":"109","author":"PT Nguyen","year":"2013","unstructured":"Nguyen PT, Tsunematsu T, Yanagisawa S, Kudo Y, Miyauchi M, Kamata N, Takata T (2013) The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. Br J Cancer 109:2248\u20132258","journal-title":"Br J Cancer"},{"key":"2714_CR155","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1200\/JCO.2016.71.8726","volume":"35","author":"A Lassaletta","year":"2017","unstructured":"Lassaletta A et al (2017) Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol 35:2934\u20132941","journal-title":"J Clin Oncol"},{"key":"2714_CR156","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/156800910793357970","volume":"10","author":"HW Lo","year":"2010","unstructured":"Lo HW (2010) Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets 10:840\u2013848","journal-title":"Curr Cancer Drug Targets"},{"key":"2714_CR157","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrc3811","volume":"14","author":"C Jones","year":"2014","unstructured":"Jones C, Baker SJ (2014) Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer 14:651\u2013661","journal-title":"Nat Rev Cancer"},{"key":"2714_CR158","first-page":"2","volume-title":"Targeted therapy for MAPK alterations in pediatric gliomas","author":"AY Truong","year":"2015","unstructured":"Truong AY, Nicolaides TP (2015) Targeted therapy for MAPK alterations in pediatric gliomas. Brain Disord, Ther Suppl, p 2"},{"key":"2714_CR159","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA et al (2014) Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol 16:1408\u20131416","journal-title":"Neuro Oncol"},{"key":"2714_CR160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","volume":"100","author":"RMA Linger","year":"2008","unstructured":"Linger RMA, Keating AK, Earp HS, Graham DK (2008) TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100:35\u201383","journal-title":"Adv Cancer Res"},{"key":"2714_CR161","first-page":"ra66","volume":"6","author":"AS Meyer","year":"2013","unstructured":"Meyer AS, Miller MA, Gertler FB, Lauffenburger DA (2013) The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells. Sci Signal 6:ra66","journal-title":"Sci Signal"},{"key":"2714_CR162","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/carcin\/bgt372","volume":"35","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Jeng YM, Chen YL, Chung L, Yuan RH (2014) Gas6\/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma. Carcinogenesis 35:769\u2013775","journal-title":"Carcinogenesis"},{"key":"2714_CR163","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.27492","volume":"61","author":"P Reichl","year":"2015","unstructured":"Reichl P et al (2015) Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma. Hepatology 61:930\u2013941","journal-title":"Hepatology"},{"key":"2714_CR164","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/1078-0432.CCR-13-1354","volume":"20","author":"PD Dunne","year":"2014","unstructured":"Dunne PD et al (2014) AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer. Clin Cancer Res 20:164\u2013175","journal-title":"Clin Cancer Res"},{"key":"2714_CR165","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/onc.2010.509","volume":"30","author":"K Vuoriluoto","year":"2011","unstructured":"Vuoriluoto K et al (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30:1436\u20131448","journal-title":"Oncogene"},{"key":"2714_CR166","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.0909333107","volume":"107","author":"C Gjerdrum","year":"2010","unstructured":"Gjerdrum C et al (2010) Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci USA 107:1124\u20131129","journal-title":"Proc Natl Acad Sci USA"},{"key":"2714_CR167","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","volume":"70","author":"SJ Holland","year":"2010","unstructured":"Holland SJ et al (2010) R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res 70:1544\u20131554","journal-title":"Cancer Res"},{"key":"2714_CR168","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/onc.2013.57","volume":"33","author":"MK Asiedu","year":"2014","unstructured":"Asiedu MK, Beauchamp-Perez FD, Ingle JN, Behrens MD, Radisky DC, Knutson KL (2014) AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells. Oncogene 33:1316\u20131324","journal-title":"Oncogene"},{"key":"2714_CR169","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1038\/onc.2013.388","volume":"33","author":"MA Cichon","year":"2014","unstructured":"Cichon MA, Szentpetery Z, Caley MP, Papadakis ES, Mackenzie IC, Brennan CH, O\u2019Toole EA (2014) The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma. Oncogene 33:4185\u20134192","journal-title":"Oncogene"},{"key":"2714_CR170","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1038\/cddis.2014.186","volume":"5","author":"Y Wang","year":"2014","unstructured":"Wang Y, Xia H, Zhuang Z, Miao L, Chen X, Cai H (2014) Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer. Cell Death. Dis 5:e1227","journal-title":"Cell Death. Dis"},{"key":"2714_CR171","first-page":"6653","volume":"7","author":"F Wu","year":"2014","unstructured":"Wu F, Li J, Jang C, Wang J, Xiong J (2014) The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. Int J Clin Exp Pathol 7:6653\u20136661","journal-title":"Int J Clin Exp Pathol"},{"key":"2714_CR172","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers LA et al (2013) An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3\u00a0K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 19:279\u2013290","journal-title":"Clin Cancer Res"},{"key":"2714_CR173","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ng.2330","volume":"44","author":"Z Zhang","year":"2012","unstructured":"Zhang Z et al (2012) Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer. Nat Genet 44:852\u2013860","journal-title":"Nat Genet"},{"key":"2714_CR174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2015.01.009","volume":"332","author":"O Martinho","year":"2015","unstructured":"Martinho O, Zucca LE, Reis RM (2015) AXL as a modulator of sunitinib response in glioblastoma cell lines. Exp Cell Res 332:1\u201310","journal-title":"Exp Cell Res"},{"key":"2714_CR175","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1073\/pnas.0510923103","volume":"103","author":"P Vajkoczy","year":"2006","unstructured":"Vajkoczy P et al (2006) Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 103:5799\u20135804","journal-title":"Proc Natl Acad Sci USA"},{"key":"2714_CR176","doi-asserted-by":"crossref","first-page":"16183","DOI":"10.18632\/oncotarget.3952","volume":"6","author":"M Vouri","year":"2015","unstructured":"Vouri M, An Q, Birt M, Pilkington GJ, Hafizi S (2015) Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells. Oncotarget 6:16183\u201316197","journal-title":"Oncotarget"},{"key":"2714_CR177","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/onc.2012.104","volume":"32","author":"Y Wang","year":"2013","unstructured":"Wang Y et al (2013) Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme. Oncogene 32:872\u2013882","journal-title":"Oncogene"},{"key":"2714_CR178","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1038\/onc.2011.588","volume":"31","author":"AE Rogers","year":"2012","unstructured":"Rogers AE, Le JP, Sather S, Pernu BM, Graham DK, Pierce AM, Keating AK (2012) Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology. Oncogene 31:4171\u20134181","journal-title":"Oncogene"},{"key":"2714_CR179","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.18632\/oncotarget.1793","volume":"5","author":"KH Knubel","year":"2014","unstructured":"Knubel KH, Pernu BM, Sufit A, Nelson S, Pierce AM, Keating AK (2014) MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme. Oncotarget 5:1338\u20131351","journal-title":"Oncotarget"},{"key":"2714_CR180","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1535-7163.MCT-09-0707","volume":"9","author":"AK Keating","year":"2010","unstructured":"Keating AK et al (2010) Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity. Mol Cancer Ther 9:1298\u20131307","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"2714_CR181","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.yexcr.2017.09.032","volume":"360","author":"MH Meel","year":"2017","unstructured":"Meel MH, Sewing ACP, Waranecki P, Metselaar DS, Wedekind LE, Koster J, van Vuurden DG, Kaspers GJL, Hulleman E (2017) Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies. Exp Cell Res 360(2):397\u2013403. https:\/\/doi.org\/10.1016\/j.yexcr.2017.09.032","journal-title":"Exp Cell Res"},{"key":"2714_CR182","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1046\/j.0014-2956.2001.02586.x","volume":"268","author":"K Friederichs","year":"2001","unstructured":"Friederichs K, Schmitz J, Weissenbach M, Heinrich PC, Schaper F (2001) Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2\/SOCS3 recruitment sites revisited. Eur J Biochem 268:6401\u20136407","journal-title":"Eur J Biochem"},{"key":"2714_CR183","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/cas.12668","volume":"106","author":"N Uddin","year":"2015","unstructured":"Uddin N, Kim RK, Yoo KC, Kim YH, Cui YH, Kim IG, Suh Y, Lee SJ (2015) Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer. Cancer Sci 106:718\u2013725","journal-title":"Cancer Sci"},{"key":"2714_CR184","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1074\/jbc.M111.295964","volume":"287","author":"H Xiong","year":"2012","unstructured":"Xiong H et al (2012) Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem 287:5819\u20135832","journal-title":"J Biol Chem"},{"key":"2714_CR185","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1227\/NEU.0b013e3181f1c0cd","volume":"67","author":"SH Kang","year":"2010","unstructured":"Kang SH, Yu MO, Park KJ, Chi SG, Park DH, Chung YG (2010) Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma. Neurosurgery 67:1386\u20131395","journal-title":"Neurosurgery"},{"key":"2714_CR186","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1038\/onc.2014.473","volume":"34","author":"D Zhao","year":"2015","unstructured":"Zhao D et al (2015) Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene 34:5447\u20135459","journal-title":"Oncogene"},{"key":"2714_CR187","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1158\/0008-5472.CAN-07-0575","volume":"67","author":"HW Lo","year":"2007","unstructured":"Lo HW et al (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67:9066\u20139076","journal-title":"Cancer Res"},{"key":"2714_CR188","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2010.03.092","volume":"394","author":"F Cao","year":"2010","unstructured":"Cao F, Hata R, Zhu P, Nakashiro K, Sakanaka M (2010) Conditional deletion of Stat3 promotes neurogenesis and inhibits astrogliogenesis in neural stem cells. Biochem Biophys Res Commun 394:843\u2013847","journal-title":"Biochem Biophys Res Commun"},{"key":"2714_CR189","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/onc.2011.409","volume":"31","author":"P Yue","year":"2012","unstructured":"Yue P, Zhang X, Paladino D, Sengupta B, Ahmad S, Holloway RW, Ingersoll SB, Turkson J (2012) Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Oncogene 31:2309\u20132322","journal-title":"Oncogene"},{"key":"2714_CR190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/ijo.2013.2195","volume":"44","author":"SS Chung","year":"2014","unstructured":"Chung SS, Giehl N, Wu Y, Vadgama JV (2014) STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits. Int J Oncol 44:403\u2013411","journal-title":"Int J Oncol"},{"key":"2714_CR191","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2014.06.023","volume":"354","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Lim J, Yang Y, Lee MS, Lim JS (2014) N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3\/Snail signaling. Cancer Lett 354:33\u201342","journal-title":"Cancer Lett"},{"key":"2714_CR192","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1186\/1471-2407-14-783","volume":"14","author":"Z Lu","year":"2014","unstructured":"Lu Z et al (2014) FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. BMC Cancer 14:783","journal-title":"BMC Cancer"},{"key":"2714_CR193","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1158\/1535-7163.MCT-11-0801","volume":"11","author":"S Kohsaka","year":"2012","unstructured":"Kohsaka S et al (2012) STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol Cancer Ther 11:1289\u20131299","journal-title":"Mol Cancer Ther"},{"key":"2714_CR194","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ijc.25416","volume":"128","author":"C Villalva","year":"2011","unstructured":"Villalva C et al (2011) STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? Int J Cancer 128:826\u2013838","journal-title":"Int J Cancer"},{"key":"2714_CR195","first-page":"1173","volume":"26","author":"Y Wang","year":"2011","unstructured":"Wang Y et al (2011) Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways. Oncol Rep 26:1173\u20131180","journal-title":"Oncol Rep"},{"key":"2714_CR196","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ijrobp.2009.12.036","volume":"77","author":"L Gao","year":"2010","unstructured":"Gao L, Li F, Dong B, Zhang J, Rao Y, Cong Y, Mao B, Chen X (2010) Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. Int J Radiat Oncol Biol Phys 77:1223\u20131231","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2714_CR197","first-page":"8058","volume":"61","author":"BH Joshi","year":"2001","unstructured":"Joshi BH, Leland P, Asher A, Prayson RA, Varricchio F, Puri RK (2001) In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res 61:8058\u20138061","journal-title":"Cancer Res"},{"key":"2714_CR198","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1215\/15228517-2007-066","volume":"10","author":"BH Joshi","year":"2008","unstructured":"Joshi BH, Puri RA, Leland P, Varricchio F, Gupta G, Kocak M, Gilbertson RJ, Puri RK (2008) Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Neuro Oncol 10:265\u2013274","journal-title":"Neuro Oncol"},{"key":"2714_CR199","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/cncr.20470","volume":"101","author":"M Kawakami","year":"2004","unstructured":"Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK (2004) Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors. Cancer 101:1036\u20131042","journal-title":"Cancer"},{"key":"2714_CR200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-008-9566-9","volume":"88","author":"H Okada","year":"2008","unstructured":"Okada H, Low KL, Kohanbash G, McDonald HA, Hamilton RL, Pollack IF (2008) Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. J Neurooncol 88:245\u2013250","journal-title":"J Neurooncol"},{"key":"2714_CR201","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/sj.onc.1210467","volume":"26","author":"Y Lee","year":"2007","unstructured":"Lee Y, Kawagoe R, Sasai K, Li Y, Russell HR, Curran T, McKinnon PJ (2007) Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26:6442\u20136447","journal-title":"Oncogene"},{"key":"2714_CR202","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/13543784.2016.1216973","volume":"25","author":"GN Gan","year":"2016","unstructured":"Gan GN, Jimeno A (2016) Emerging from their burrow: Hedgehog pathway inhibitors for cancer. Expert Opin Investig Drugs 25:1153\u20131166","journal-title":"Expert Opin Investig Drugs"},{"key":"2714_CR203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1677\/ERC-07-0108","volume":"14","author":"V Fendrich","year":"2007","unstructured":"Fendrich V, Waldmann J, Esni F, Ramaswamy A, Mullendore M, Buchholz M, Maitra A, Feldmann G (2007) Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocr Relat Cancer 14:865\u2013874","journal-title":"Endocr Relat Cancer"},{"key":"2714_CR204","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/156652409789105570","volume":"9","author":"Y Katoh","year":"2009","unstructured":"Katoh Y, Katoh M (2009) Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 9:873\u2013886","journal-title":"Curr Mol Med"},{"key":"2714_CR205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1750-3639.2011.00505.x","volume":"21","author":"M Mimeault","year":"2011","unstructured":"Mimeault M, Batra SK (2011) Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies. Brain Pathol 21:479\u2013500","journal-title":"Brain Pathol"},{"key":"2714_CR206","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1158\/1078-0432.CCR-10-1624","volume":"16","author":"KC Schreck","year":"2010","unstructured":"Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG (2010) The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res 16:6060\u20136070","journal-title":"Clin Cancer Res"},{"key":"2714_CR207","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s13277-014-2948-z","volume":"36","author":"J Lei","year":"2015","unstructured":"Lei J et al (2015) Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer. Tumour Biol 36:3119\u20133126","journal-title":"Tumour Biol"},{"key":"2714_CR208","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","volume":"71","author":"YA Yoo","year":"2011","unstructured":"Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK, Kim HK, Kim JS, Oh SC (2011) Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 71:7061\u20137070","journal-title":"Cancer Res"},{"key":"2714_CR209","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1349-7006.2011.01943.x","volume":"102","author":"T Takezaki","year":"2011","unstructured":"Takezaki T, Hide T, Takanaga H, Nakamura H, Kuratsu J, Kondo T (2011) Essential role of the Hedgehog signaling pathway in human glioma-initiating cells. Cancer Sci 102:1306\u20131312","journal-title":"Cancer Sci"},{"key":"2714_CR210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/path.4349","volume":"234","author":"GN Yan","year":"2014","unstructured":"Yan GN et al (2014) Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. J Pathol 234:11\u201322","journal-title":"J Pathol"},{"key":"2714_CR211","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1535370214565989","volume":"240","author":"MF Chiang","year":"2015","unstructured":"Chiang MF et al (2015) Modulation of Sonic hedgehog signaling and WW domain containing oxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells. Exp Biol Med (Maywood.) 240:392\u2013399","journal-title":"Exp Biol Med (Maywood.)"},{"key":"2714_CR212","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/neuonc\/not011","volume":"15","author":"J Fu","year":"2013","unstructured":"Fu J, Rodova M, Nanta R, Meeker D, Van Veldhuizen PJ, Srivastava RK, Shankar S (2013) NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Neuro Oncol 15:691\u2013706","journal-title":"Neuro Oncol"},{"key":"2714_CR213","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2119\/molmed.2010.00062","volume":"17","author":"IV Ulasov","year":"2011","unstructured":"Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS (2011) Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Mol Med 17:103\u2013112","journal-title":"Mol Med"},{"key":"2714_CR214","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","volume":"108","author":"M Monje","year":"2011","unstructured":"Monje M et al (2011) Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci USA 108:4453\u20134458","journal-title":"Proc Natl Acad Sci USA"},{"key":"2714_CR215","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/1078-0432.CCR-05-2570","volume":"12","author":"L Miele","year":"2006","unstructured":"Miele L (2006) Notch signaling. Clin Cancer Res 12:1074\u20131079","journal-title":"Clin Cancer Res"},{"key":"2714_CR216","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1476-4598-13-247","volume":"13","author":"C Cenciarelli","year":"2014","unstructured":"Cenciarelli C et al (2014) PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment. Mol Cancer 13:247","journal-title":"Mol Cancer"},{"key":"2714_CR217","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/stem.1767","volume":"33","author":"PO Guichet","year":"2015","unstructured":"Guichet PO et al (2015) Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells. Stem Cells 33:21\u201334","journal-title":"Stem Cells"},{"key":"2714_CR218","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/1566524014666140331230411","volume":"14","author":"X Chen","year":"2014","unstructured":"Chen X, Xiao W, Liu X, Zeng M, Luo L, Wu M, Ye S, Liu Y (2014) Blockade of Jagged\/Notch pathway abrogates transforming growth factor beta2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. Curr Mol Med 14:523\u2013534","journal-title":"Curr Mol Med"},{"key":"2714_CR219","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/138945010791170860","volume":"11","author":"Z Wang","year":"2010","unstructured":"Wang Z, Li Y, Kong D, Sarkar FH (2010) The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets 11:745\u2013751","journal-title":"Curr Drug Targets"},{"key":"2714_CR220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2013.08.027","volume":"341","author":"I Espinoza","year":"2013","unstructured":"Espinoza I, Miele L (2013) Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. Cancer Lett 341:41\u201345","journal-title":"Cancer Lett"},{"key":"2714_CR221","doi-asserted-by":"crossref","first-page":"e77299","DOI":"10.1371\/journal.pone.0077299","volume":"8","author":"MA Alqudah","year":"2013","unstructured":"Alqudah MA, Agarwal S, Al-Keilani MS, Sibenaller ZA, Ryken TC, Assem M (2013) NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR. PLoS One 8:e77299","journal-title":"PLoS One"},{"key":"2714_CR222","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jocn.2010.07.131","volume":"18","author":"L Jiang","year":"2011","unstructured":"Jiang L, Wu J, Chen Q, Hu X, Li W, Hu G (2011) Notch1 expression is upregulated in glioma and is associated with tumor progression. J Clin Neurosci 18:387\u2013390","journal-title":"J Clin Neurosci"},{"key":"2714_CR223","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1349-7006.2011.02154.x","volume":"103","author":"X Zhang","year":"2012","unstructured":"Zhang X et al (2012) Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation. Cancer Sci 103:181\u2013190","journal-title":"Cancer Sci"},{"key":"2714_CR224","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1582-4934.2008.00307.x","volume":"13","author":"E Hulleman","year":"2009","unstructured":"Hulleman E et al (2009) A role for the transcription factor HEY1 in glioblastoma. J Cell Mol Med 13:136\u2013146","journal-title":"J Cell Mol Med"},{"key":"2714_CR225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-11-82","volume":"11","author":"YY Hu","year":"2011","unstructured":"Hu YY et al (2011) Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer 11:82","journal-title":"BMC Cancer"},{"key":"2714_CR226","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4161\/cbt.24595","volume":"14","author":"K Kristoffersen","year":"2013","unstructured":"Kristoffersen K, Villingshoj M, Poulsen HS, Stockhausen MT (2013) Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures. Cancer Biol Ther 14:625\u2013637","journal-title":"Cancer Biol Ther"},{"key":"2714_CR227","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/neuonc\/not168","volume":"16","author":"P Dell\u2019albani","year":"2014","unstructured":"Dell\u2019albani P et al (2014) Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. Neuro Oncol 16:204\u2013216","journal-title":"Neuro Oncol"},{"key":"2714_CR228","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1158\/0008-5472.CAN-10-1378","volume":"70","author":"CA Gilbert","year":"2010","unstructured":"Gilbert CA, Daou MC, Moser RP, Ross AH (2010) Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 70:6870\u20136879","journal-title":"Cancer Res"},{"key":"2714_CR229","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/stem.429","volume":"28","author":"KE Hovinga","year":"2010","unstructured":"Hovinga KE et al (2010) Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 28:1019\u20131029","journal-title":"Stem Cells"},{"key":"2714_CR230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/stem.542","volume":"28","author":"J Wang","year":"2010","unstructured":"Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28:17\u201328","journal-title":"Stem Cells"},{"key":"2714_CR231","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/stem.254","volume":"28","author":"X Fan","year":"2010","unstructured":"Fan X et al (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28:5\u201316","journal-title":"Stem Cells"},{"key":"2714_CR232","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","volume":"74","author":"IC Taylor","year":"2015","unstructured":"Taylor IC et al (2015) Disrupting NOTCH slows diffuse intrinsic pontine glioma growth, enhances radiation sensitivity, and shows combinatorial efficacy with bromodomain inhibition. J Neuropathol Exp Neurol 74:778\u2013790","journal-title":"J Neuropathol Exp Neurol"},{"key":"2714_CR233","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/1541-7786.MCR-10-0214","volume":"9","author":"D Luo","year":"2011","unstructured":"Luo D, Wang J, Li J, Post M (2011) Mouse snail is a target gene for HIF. Mol Cancer Res 9:234\u2013245","journal-title":"Mol Cancer Res"},{"key":"2714_CR234","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s10620-013-2841-4","volume":"58","author":"GH Zhu","year":"2013","unstructured":"Zhu GH, Huang C, Feng ZZ, Lv XH, Qiu ZJ (2013) Hypoxia-induced snail expression through transcriptional regulation by HIF-1alpha in pancreatic cancer cells. Dig Dis Sci 58:3503\u20133515","journal-title":"Dig Dis Sci"},{"key":"2714_CR235","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1007\/s13277-014-2056-0","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y et al (2014) HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT. Tumour Biol 35:8103\u20138114","journal-title":"Tumour Biol"},{"key":"2714_CR236","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s12035-014-8935-y","volume":"52","author":"B Lv","year":"2015","unstructured":"Lv B et al (2015) CXCR4 signaling induced epithelial-mesenchymal transition by PI3\u00a0K\/AKT and ERK pathways in glioblastoma. Mol Neurobiol 52:1263\u20131268","journal-title":"Mol Neurobiol"},{"key":"2714_CR237","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1038\/onc.2012.530","volume":"32","author":"Y Xi","year":"2013","unstructured":"Xi Y et al (2013) Identification of pY654-beta-catenin as a critical co-factor in hypoxia-inducible factor-1alpha signaling and tumor responses to hypoxia. Oncogene 32:5048\u20135057","journal-title":"Oncogene"},{"key":"2714_CR238","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","volume":"181","author":"ME Hardee","year":"2012","unstructured":"Hardee ME, Zagzag D (2012) Mechanisms of glioma-associated neovascularization. Am J Pathol 181:1126\u20131141","journal-title":"Am J Pathol"},{"key":"2714_CR239","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ajpath.2017.01.010","volume":"187","author":"S Mahase","year":"2017","unstructured":"Mahase S, Rattenni RN, Wesseling P, Leenders W, Baldotto C, Jain R, Zagzag D (2017) Hypoxia-mediated mechanisms associated with antiangiogenic treatment resistance in glioblastomas. Am J Pathol 187:940\u2013953","journal-title":"Am J Pathol"},{"key":"2714_CR240","doi-asserted-by":"crossref","first-page":"e0120296","DOI":"10.1371\/journal.pone.0120296","volume":"10","author":"SW Kim","year":"2015","unstructured":"Kim SW et al (2015) Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs. PLoS One 10:e0120296","journal-title":"PLoS One"},{"key":"2714_CR241","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","volume":"129","author":"B Keith","year":"2007","unstructured":"Keith B, Simon MC (2007) Hypoxia inducible factors, stem cells and cancer. Cell 129:465\u2013472","journal-title":"Cell"},{"key":"2714_CR242","doi-asserted-by":"crossref","first-page":"21306","DOI":"10.1073\/pnas.0906432106","volume":"106","author":"A Franovic","year":"2009","unstructured":"Franovic A, Holterman CE, Payette J, Lee S (2009) Human cancers converge at the HIF-2alpha oncogenic axis. Proc Natl Acad Sci USA 106:21306\u201321311","journal-title":"Proc Natl Acad Sci USA"},{"key":"2714_CR243","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/pros.22776","volume":"74","author":"KH Cho","year":"2014","unstructured":"Cho KH, Choi MJ, Jeong KJ, Kim JJ, Hwang MH, Shin SC, Park CG, Lee HY (2014) A ROS\/STAT3\/HIF-1alpha signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion. Prostate 74:528\u2013536","journal-title":"Prostate"},{"key":"2714_CR244","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","volume":"8","author":"JM Heddleston","year":"2009","unstructured":"Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8:3274\u20133284","journal-title":"Cell Cycle"},{"key":"2714_CR245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1541-7786.MCR-08-0360","volume":"7","author":"AM McCord","year":"2009","unstructured":"McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, Tofilon PJ (2009) Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 7:489\u2013497","journal-title":"Mol Cancer Res"},{"key":"2714_CR246","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1634\/stemcells.2008-0402","volume":"27","author":"F Pistollato","year":"2009","unstructured":"Pistollato F et al (2009) Hypoxia and HIF1alpha repress the differentiative effects of BMPs in high-grade glioma. Stem Cells 27:7\u201317","journal-title":"Stem Cells"},{"key":"2714_CR247","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li Z et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501\u2013513","journal-title":"Cancer Cell"},{"key":"2714_CR248","first-page":"2323","volume":"6","author":"CG Dong","year":"2013","unstructured":"Dong CG, Wu WK, Feng SY, Yu J, Shao JF, He GM (2013) Suppressing the malignant phenotypes of glioma cells by lentiviral delivery of small hairpin RNA targeting hypoxia-inducible factor-1alpha. Int J Clin Exp Pathol 6:2323\u20132332","journal-title":"Int J Clin Exp Pathol"},{"key":"2714_CR249","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1476-4598-9-133","volume":"9","author":"O Mendez","year":"2010","unstructured":"Mendez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D (2010) Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 9:133","journal-title":"Mol Cancer"},{"key":"2714_CR250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10072-012-1010-4","volume":"34","author":"SH Shen","year":"2013","unstructured":"Shen SH, Kwan AL, Chen YY, Wang ZX (2013) Effect of silencing HIF-1alpha on proliferation, invasion and migration of glioblastoma U87 cells. Neurol Sci 34:365\u2013371","journal-title":"Neurol Sci"},{"key":"2714_CR251","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1158\/1078-0432.CCR-06-2692","volume":"13","author":"DL Gillespie","year":"2007","unstructured":"Gillespie DL, Whang K, Ragel BT, Flynn JR, Kelly DA, Jensen RL (2007) Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res 13:2441\u20132448","journal-title":"Clin Cancer Res"},{"key":"2714_CR252","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2014.05.009","volume":"89","author":"Z Luo","year":"2015","unstructured":"Luo Z et al (2015) Silencing of HIF-1alpha enhances the radiation sensitivity of human glioma growth in vitro and in vivo. Neuropharmacology 89:168\u2013174","journal-title":"Neuropharmacology"},{"key":"2714_CR253","first-page":"1865","volume":"63","author":"S Khatua","year":"2003","unstructured":"Khatua S et al (2003) Overexpression of the EGFR\/FKBP12\/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 63:1865\u20131870","journal-title":"Cancer Res"},{"key":"2714_CR254","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/onc.2014.122","volume":"34","author":"I Appolloni","year":"2015","unstructured":"Appolloni I, Barilari M, Caviglia S, Gambini E, Reisoli E, Malatesta P (2015) A cadherin switch underlies malignancy in high-grade gliomas. Oncogene 34:1991\u20132002","journal-title":"Oncogene"},{"key":"2714_CR255","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.devcel.2006.10.010","volume":"11","author":"M Perez-Moreno","year":"2006","unstructured":"Perez-Moreno M, Fuchs E (2006) Catenins: keeping cells from getting their signals crossed. Dev Cell 11:601\u2013612","journal-title":"Dev Cell"},{"key":"2714_CR256","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0092-8674(03)00108-9","volume":"112","author":"M Perez-Moreno","year":"2003","unstructured":"Perez-Moreno M, Jamora C, Fuchs E (2003) Sticky business: orchestrating cellular signals at adherens junctions. Cell 112:535\u2013548","journal-title":"Cell"},{"key":"2714_CR257","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","volume":"28","author":"O Schmalhofer","year":"2009","unstructured":"Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151\u2013166","journal-title":"Cancer Metastasis Rev"},{"key":"2714_CR258","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1016\/j.cub.2004.12.058","volume":"15","author":"M Bienz","year":"2005","unstructured":"Bienz M (2005) beta-Catenin: a pivot between cell adhesion and Wnt signalling. Curr Biol 15:R64\u2013R67","journal-title":"Curr Biol"},{"key":"2714_CR259","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1038\/onc.2013.310","volume":"33","author":"X Qian","year":"2014","unstructured":"Qian X et al (2014) N-cadherin\/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem\/progenitor cell-like properties. Oncogene 33:3411\u20133421","journal-title":"Oncogene"},{"key":"2714_CR260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10735-013-9540-5","volume":"45","author":"F Liang","year":"2014","unstructured":"Liang F, Zhang S, Wang B, Qiu J, Wang Y (2014) Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-kappaB pathway. J Mol Histol 45:141\u2013151","journal-title":"J Mol Histol"},{"key":"2714_CR261","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cellsig.2012.07.002","volume":"24","author":"KK Velpula","year":"2012","unstructured":"Velpula KK, Rehman AA, Chelluboina B, Dasari VR, Gondi CS, Rao JS, Veeravalli KK (2012) Glioma stem cell invasion through regulation of the interconnected ERK, integrin alpha6 and N-cadherin signaling pathway. Cell Signal 24:2076\u20132084","journal-title":"Cell Signal"},{"key":"2714_CR262","first-page":"3104","volume":"8","author":"C Zhao","year":"2015","unstructured":"Zhao C, Li X, Su C, Li J, Cheng N, Ren S, Chen X, Zhou C (2015) High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients. Int J Clin Exp Pathol 8:3104\u20133109","journal-title":"Int J Clin Exp Pathol"},{"key":"2714_CR263","first-page":"150","volume":"17","author":"Y Guo","year":"2013","unstructured":"Guo Y, Yin J, Zha L, Wang Z (2013) Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-beta, and E-cadherin expression in gastric carcinoma. Contemp Oncol (Pozn) 17:150\u2013155","journal-title":"Contemp Oncol (Pozn)"},{"key":"2714_CR264","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S031716710001430X","volume":"40","author":"W Wu","year":"2013","unstructured":"Wu W, Tian Y, Wan H, Song Y, Li J, Zhang L (2013) The expressions of Wnt\/beta-catenin pathway-related components in brainstem gliomas. Can J Neurol Sci 40:355\u2013360","journal-title":"Can J Neurol Sci"},{"key":"2714_CR265","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00207454.2012.758123","volume":"123","author":"W Wu","year":"2013","unstructured":"Wu W, Tian Y, Wan H, Ma J, Song Y, Wang Y, Zhang L (2013) Expression of beta-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations. Int J Neurosci 123:318\u2013323","journal-title":"Int J Neurosci"},{"key":"2714_CR266","doi-asserted-by":"crossref","first-page":"e13665","DOI":"10.1371\/journal.pone.0013665","volume":"5","author":"LJ Lewis-Tuffin","year":"2010","unstructured":"Lewis-Tuffin LJ, Rodriguez F, Giannini C, Scheithauer B, Necela BM, Sarkaria JN, Anastasiadis PZ (2010) Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 5:e13665","journal-title":"PLoS One"},{"key":"2714_CR267","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1755-8794-2-28","volume":"2","author":"LW Harris","year":"2009","unstructured":"Harris LW, Lockstone HE, Khaitovich P, Weickert CS, Webster MJ, Bahn S (2009) Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med Genom 2:28","journal-title":"BMC Med Genom"},{"key":"2714_CR268","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ijc.28836","volume":"135","author":"G Reifenberger","year":"2014","unstructured":"Reifenberger G et al (2014) Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. Int J Cancer 135:1822\u20131831","journal-title":"Int J Cancer"},{"key":"2714_CR269","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1021\/jm501177w","volume":"57","author":"AH Mohedas","year":"2014","unstructured":"Mohedas AH et al (2014) Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. J Med Chem 57:7900\u20137915","journal-title":"J Med Chem"},{"key":"2714_CR270","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1253799","volume":"346","author":"K Funato","year":"2014","unstructured":"Funato K, Major T, Lewis PW, Allis CD, Tabar V (2014) Use of human embryonic stem cells to model pediatric gliomas with H3.3K27\u00a0M histone mutation. Science 346:1529\u20131533","journal-title":"Science"},{"key":"2714_CR271","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340:857\u2013861","journal-title":"Science"},{"key":"2714_CR272","doi-asserted-by":"crossref","first-page":"11316","DOI":"10.1038\/ncomms11316","volume":"7","author":"N Justin","year":"2016","unstructured":"Justin N et al (2016) Structural basis of oncogenic histone H3K27\u00a0M inhibition of human polycomb repressive complex 2. Nat Commun 7:11316","journal-title":"Nat Commun"},{"issue":"635\u2013652","key":"2714_CR273","first-page":"e6","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S et al (2017) Transcriptional dependencies in diffuse intrinsic pontine glioma. Cancer Cell 31(635\u2013652):e6","journal-title":"Cancer Cell"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T20:46:24Z","timestamp":1719607584000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":273,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2714"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2714-7","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}